Clinical Trial: An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia

Brief Summary: The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH).